$109 Million is the total value of Opus Point Partners Management, LLC's 67 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | MERCK & CO INC | $5,364,000 | +0.9% | 83,700 | 0.0% | 4.91% | +24.5% | |
| BMY | BRISTOL MYERS SQUIBB CO | $5,015,000 | +2.5% | 90,000 | 0.0% | 4.59% | +26.5% | |
| ALXN | ALEXION PHARMACEUTICALS INCcall | $4,258,000 | +0.3% | 35,000 | 0.0% | 3.90% | +23.8% | |
| AZN | ASTRAZENECA PLCsponsored adr | $4,091,000 | +9.5% | 120,000 | 0.0% | 3.75% | +35.1% | |
| PFE | PFIZER INC | $3,772,000 | -1.8% | 112,300 | 0.0% | 3.46% | +21.1% | |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $2,587,000 | +2.3% | 60,000 | 0.0% | 2.37% | +26.2% | |
| BMY | BRISTOL MYERS SQUIBB COcall | $2,508,000 | +2.5% | 45,000 | 0.0% | 2.30% | +26.5% | |
| LLY | LILLY ELI & COcall | $1,235,000 | -2.1% | 15,000 | 0.0% | 1.13% | +20.7% | |
| GILD | GILEAD SCIENCES INCcall | $706,000 | +4.0% | 10,000 | 0.0% | 0.65% | +28.4% | |
| AXGT | AXOVANT SCIENCES LTD | $404,000 | +55.4% | 17,425 | 0.0% | 0.37% | +91.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.